This kit is used for in vitro qualitative detection of high-risk human papillomavirus (HPV) nucleic acid DNA in female cervical epithelial cell samples. It is suitable for auxiliary diagnosis and drug treatment efficacy monitoring of 15 high-risk human papillomavirus infections, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68, and can simultaneously classify and identify high-risk human papillomavirus type 16 and high-risk human papillomavirus type 18.

Short Turnaround Time for Reporting: Completion of the entire process, from sample processing to result reporting, within 90 minutes.

Simple Operation: Paired with the Bioer fully automatic nucleic acid extractor, extraction for 96 samples takes only 15 minutes, effectively enhancing laboratory workflow efficiency.

Sample Collection Monitoring: The non-competitive human β-Globin internal reference can be used to assess sample quality and PCR inhibition factors, while preventing false-negative results.

Anti-Contamination System: UDG enzyme and dUTP contamination control measures thoroughly degrade potential product contamination, avoiding false-positive results.

Four-Channel Fluorescence Detection: FAM, HEX, ROX, CY5